FTI GOVERNMENT AFFAIRS for PERRIGO, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Monitor issues as they relate to the implementation of tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KYLE CORMNEY | — |
| THOMAS CRAWFORD | — |
| DAVID PATRICK ROBERTSON | — |
| SCOTT STYLES | — |
Health Issues HCR
Dextromethorphan, Pseudoephedrine restriction issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS CRAWFORD | — |
| DAVID PATRICK ROBERTSON | — |
Pharmacy PHA
Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", H.R. 5333. "Over-the-Counter Drug Safety, Innovation, and Reform Act", S. 2315.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS CRAWFORD | — |
| DAVID PATRICK ROBERTSON | — |
| SCOTT STYLES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.